With the addition of 26 new members, The FASEB Journal recently increased the size of its editorial board by 50 percent. The editors were chosen to expand the interdisciplinary journal’s research expertise to new areas, and to deepen capabilities in established subjects.
In addition, a new associate editor joins the ranks of The FASEB Journal: Chen Dong of Tsinghua University in China, who brings expertise in immunology and immuno-oncology.
“With an impact factor of 5.595, The FASEB Journal is already sought out by investigators in a variety of fields,” said Thoru Pederson, Editor-in-Chief. “With the appointment of Dr. Dong and this robust expansion, researchers should know that the journal is a strong option for an even broader scope of exciting work. And in keeping with FASEB’s commitment to diversity, equity, and inclusion, more than 50 percent of the new editors are women,” Pederson said.
The new editorial board members are:
Immunology: Jürgen Bernhagen, University of Munich; Yeonseok Chung, Seoul National University; and Mark Poznansky, Dana Farber Cancer Institute, Harvard Medical School
Hepatology: Patrizia Farci, National Institute of Allergy and Infectious Diseases; David Shafritz, Albert Einstein College of Medicine; and Mengwei Zang, UT Health San Antonio
Dermatology: Ethan Lerner, Massachusetts General Hospital, Harvard Medical School
Cell Biology: Elizabeth Luna, University of Massachusetts Medical School; Rita Miller, National Science Foundation; and Karen Ridge, Northwestern University Feinberg School of Medicine
Pulmonary biology and pathology: Karen Ridge, Northwestern University Feinberg School of Medicine
The microbiome: Megan Baldridge, Washington University School of Medicine
Cancer: Kimbaz Alavian, Imperial College, London; Katherine Van Loon, University of California San Francisco; and Wen Xue, University of Massachusetts Medical School
Muscle: Laurie Goodyear, Joslin Diabetes Center, Harvard Medical School; and Alessandra Sacco, Sanford Burnham Prebys Medical Discovery Institute
Male Fertility: Pablo Visconti, University of Massachusetts at Amherst
Virology: Anna Marie Skalka, Fox Chase Cancer Center; and Deborah Spector, University of California San Diego
Cardiovascular biology and pathology: Jane Freedman, University of Massachusetts Medical School; Joseph Loscalzo, Brigham and Women’s Hospital, Harvard Medical School; and Elizabeth Murphy, National Heart, Lung, and Blood Institute
In addition, three FASEB member societies have appointed new members to the editorial board:
The American Society for Bone and Mineral Research: Thomas Lang, University of California San Francisco
American Association of Anatomists: Samuel Marquez, State University of New York Downstate Medical Center
Association for Molecular Pathology: Ronald Pryzgodski, U.S. Department of Veterans Affairs